47.578525, 7.597147
PDF / print export
BioVersys
Basel, Switzerland
- Verified lead
- Marc Gitzinger
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Anti-Infectives Discovery, Antibacterial R&D, and Drug-Resistance Biology
- Review cycle
- May 2026
- Full address
- Hochbergerstrasse 60C, CH-4057 Basel, Switzerland
- Site coordinates
- 47.578525, 7.597147
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official BioVersys management page confirming Marc Gitzinger as CEO.
- Editorial note
- Basel antibacterial-discovery node combining resistance-biology expertise, translational anti-infectives programs, and SME-scale clinical pipeline execution.
Anti-Infectives Discovery, Antibacterial R&D, and Drug-Resistance Biology
Drug-discovery quality systems, Clinical-development governance
Basel antibacterial-discovery node combining resistance-biology expertise, translational anti-infectives programs, and SME-scale clinical pipeline execution.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Basel, Switzerland
BioVersys
Anti-Infectives Discovery, Antibacterial R&D, and Drug-Resistance Biology · Swiss anti-infectives discovery hub
Basel antibacterial-discovery node combining resistance-biology expertise, translational anti-infectives programs, and SME-scale clinical pipeline execution.
- Lead
- Marc Gitzinger (verified ↗)
- Address
- Hochbergerstrasse 60C, CH-4057 Basel, Switzerland (source ↗)
- Compliance
- GLP
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Swiss anti-infectives discovery hub
- Capabilities
- Antibacterial Discovery · Resistance Biology · Translational Anti-Infectives
- Founded
- 2008
- Headcount
- 51-200
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Marc Gitzinger
Chief Executive Officer
Full addressHochbergerstrasse 60C, CH-4057 Basel, Switzerland
Site coordinates47.578525, 7.597147
Review cycleMay 2026
Physical site source
Official BioVersys contact page listing Hochbergerstrasse 60C, Basel.
Open sourceSwiss anti-infectives discovery hub
Basel, Switzerland. Anti-Infectives Discovery, Antibacterial R&D, and Drug-Resistance Biology. Review completed on 14 Mar 2026.
Swiss and EU therapeutic-development oversight
Drug-discovery quality systems, Clinical-development governance
Anti-Infectives Discovery, Antibacterial R&D, and Drug-Resistance Biology
Basel antibacterial-discovery node combining resistance-biology expertise, translational anti-infectives programs, and SME-scale clinical pipeline execution.
Editorial note
BioVersys adds a source-backed Swiss anti-infectives SME node with a named 2026 chief executive and a disclosed Basel physical site.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Antibacterial Discovery
Resistance Biology
Translational Anti-Infectives
Clinical Development Planning
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Discovery laboratories
Microbiology platforms
Translational research infrastructure
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- VERIFIED ACTIVE 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is BioVersys located?
- BioVersys operates from Hochbergerstrasse 60C, CH-4057 Basel, Switzerland, Basel, Switzerland.
- Who runs BioVersys?
- BioVersys is led by Marc Gitzinger, Chief Executive Officer. Verified 14 Mar 2026.
- What does BioVersys do?
- Basel antibacterial-discovery node combining resistance-biology expertise, translational anti-infectives programs, and SME-scale clinical pipeline execution. Core capabilities: Antibacterial Discovery, Resistance Biology, Translational Anti-Infectives, Clinical Development Planning.
Editorial context
Related technical briefs
Briefs that name Basel as a covered market or city.